Nanotechnology Advances in Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (10 April 2018) | Viewed by 62923
Special Issue Editors
Interests: 3D printing; bioprinting; drug delivery; electrospinning; medical devices; pharmaceutics; microfluidics
Special Issues, Collections and Topics in MDPI journals
Interests: 3D printing technologies for pharmaceutical dosage forms or novel medical devices (microneedles, bioresorbable scaffolds); continuous manufacturing processes for the development of medicinal products; nanomaterial synthesis and surface modification for cancer treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over the course of the 20th century, formulations for drug delivery began to slowly move from traditional multicomponent microtechnology-based systems to multicomponent nanotechnology-based systems. Now, in the 21st century, multicomponent nanotechnology-based systems are firmly established as the future of drug delivery within pharmaceutical sciences for a number of reasons, including greater control of drug release rates, targeted drug delivery and greater ease at overcoming both physicochemical and physiological barriers to drug absorption compared with traditional systems.
Nanotechnologies offer potentially massive benefits to society, the environment and health, since they can help us improve our quality of life and have better diagnoses and treatment of diseases. Nanocarriers for drug delivery have been an active area of research, and formulation is a cross-discipline activity requiring multiple skills to ensure that the required product performance is achieved by the judicious combination and control of active ingredient, excipients and manufacturing process.
This Special Issue will address new developments in the area of nanotechnology for cancer drug delivery, covering recent advantages and future directions on nano-based systems targeting cancer.
Preference will be awarded to papers that demonstrate contributions from scientists that provide interdisciplinary approaches to understanding pharmaceutical processing and drug delivery for cancer treatment. Original research papers and review articles are welcomed.
Dr. Dimitrios A. Lamprou
Prof. Dr. Dennis Douroumis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
Active and passive targeting
Bioconjugation
Cancer treatment
Formulation
Encapsulation
High pressure homogenization
Liposomes
Nanoparticles
Nanomedicine
Solid solutions
Solid lipid nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
